ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $92,000 | 0.0% | 4,275 | 0.0% | 0.00% | -20.0% |
Q4 2020 | $92,000 | +46.0% | 4,275 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $63,000 | -34.4% | 4,275 | 0.0% | 0.01% | -33.3% |
Q2 2020 | $96,000 | +47.7% | 4,275 | 0.0% | 0.01% | +28.6% |
Q1 2020 | $65,000 | -5.8% | 4,275 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $69,000 | +187.5% | 4,275 | +533.3% | 0.01% | +133.3% |
Q3 2019 | $24,000 | -36.8% | 675 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $38,000 | -22.4% | 675 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $49,000 | +14.0% | 675 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $43,000 | -14.0% | 675 | 0.0% | 0.01% | -14.3% |
Q3 2018 | $50,000 | -9.1% | 675 | 0.0% | 0.01% | -12.5% |
Q2 2018 | $55,000 | -21.4% | 675 | 0.0% | 0.01% | -27.3% |
Q1 2018 | $70,000 | +2.9% | 675 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $68,000 | +15.3% | 675 | -60.3% | 0.01% | -15.4% |
Q3 2017 | $59,000 | – | 1,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |